Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer

by Karthaus, Meinolf, Hofheinz, Ralf-Dieter, Mineur, Laurent, Letocha, Henry, Greil, Richard, Thaler, Josef, Fernebro, Eva, Oliner, Kelly S, Boedigheimer, Michael, Twomey, Brian, Zhang, Ying, Demonty, Gaston, Köhne, Claus-Henning
Published 2016

Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel

by Choudhary, Ashish, Mambo, Elizabeth, Sanford, Tiffany, Boedigheimer, Michael, Twomey, Brian, Califano, Joseph, Hadd, Andrew, Oliner, Kelly S, Beaudenon, Sylvie, Latham, Gary J, Adai, Alex T
Published 2014

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

by Diaz, Luis A., Williams, Richard, Wu, Jian, Kinde, Isaac, Hecht, J. Randolph, Berlin, Jordan, Allen, Benjamin, Bozic, Ivana, Reiter, Johannes G., Nowak, Martin A., Kinzler, Kenneth W., Oliner, Kelly S., Vogelstein, Bert
Published 2012

Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus

by Welcher, Andrew A., Boedigheimer, Michael, Kivitz, Alan J., Amoura, Zahir, Buyon, Jill, Rudinskaya, Alla, Latinis, Kevin, Chiu, Kit, Oliner, Kelly S., Damore, Michael A., Arnold, Gregory E., Sohn, Winnie, Chirmule, Narendra, Goyal, Lovely, Banfield, Christopher, Chung, James B.
Published 2015